This topic contains a solution. Click here to go to the answer

Author Question: The best way to protect the validity of an experiment is through the use of _____. a. nominal ... (Read 33 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
The best way to protect the validity of an experiment is through the use of _____.
 
  a. nominal scaling of variables c. random assignment
  b. random sampling d. representative sampling

Question 2

In the equation Y = bX + a, b is a(n) _________.
 
  a. independent variable
  b. dependent variable
  c. constant
  d. coefficient
  e. constant and coefficient



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nixon_s

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

C
Internal validity is maximized via random assignment of participants to treatment conditions. A random sample is not essential to experiments.

Answer to Question 2

E





 

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library